• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by American Well Corporation

    4/23/25 3:38:18 PM ET
    $AMWL
    Business Services
    Consumer Discretionary
    Get the next $AMWL alert in real time by email
    DEFA14A
    false0001393584DEFA14A00013935842024-01-012024-12-31

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No. )

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐ Preliminary Proxy Statement

    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐ Definitive Proxy Statement

    ☒ Definitive Additional Materials

    ☐ Soliciting Material under §240.14a-12

    AMERICAN WELL CORPORATION

    (Name of registrant as specified in its charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒ No fee required.

    ☐ Fee paid previously with preliminary materials.

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     


     

    img152362000_0.jpg

    AMERICAN WELL CORPORATION C/O BROADRIDGE P.O. BOX 1342 BRENTWOOD, NY 11717 V46357-P04358 You invested in AMERICAN WELL CORPORATION and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on June 18, 2024. Get informed before you vote View the Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 4, 2024. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Your Vote Counts! AMERICAN WELL CORPORATION 2024 Annual Meeting Vote by June 17, 2024 11:59 PM ET For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote Virtually at the Meeting* June 18, 2024 10:00 AM, Eastern Time Virtually at: www.virtualshareholdermeeting.com/AMWL2024 *Please check the meeting materials for any special requirements for meeting attendance.
    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. To elect three Class II directors to serve until the 2028 annual meeting of stockholders 01) Mr. Stephen Schlegel 02) Dr. Delos (Toby) Cosgrove 03) Ms. Rivka Goldwasser For 2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 For 3. To approve, on an advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company’s proxy statement For Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V71679-P27990

     


     

    img152362000_1.jpg

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. To elect three Class II directors to serve until the 2028 annual meeting of stockholders 01) Mr. Stephen Schlegel 02) Dr. Delos (Toby) Cosgrove 03) Ms. Rivka Goldwasser For 2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 For 3. To approve, on an advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company’s proxy statement For Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V71679-P27990

     


    Get the next $AMWL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMWL

    DatePrice TargetRatingAnalyst
    1/13/2025$15.00Equal Weight → Overweight
    Wells Fargo
    8/3/2023$5.00 → $2.50Overweight → Equal-Weight
    Morgan Stanley
    3/23/2023$5.00 → $2.50Outperform → Market Perform
    TD Cowen
    2/27/2023$5.00 → $3.50Overweight → Neutral
    Piper Sandler
    1/4/2023$4.20Neutral → Buy
    BofA Securities
    9/7/2022$5.00Hold
    Truist
    4/14/2022$6.00Buy
    Guggenheim
    4/1/2022$5.00Neutral
    Credit Suisse
    More analyst ratings

    $AMWL
    Financials

    Live finance-specific insights

    See more
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to report first quarter 2025 operating results

      BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Amwell offers payers and

      4/17/25 7:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for Fourth Quarter and Full Year 2024

      BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/zsp4abpw. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. Abo

      2/12/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by American Well Corporation

      SC 13G/A - American Well Corp (0001393584) (Subject)

      11/12/24 4:43:25 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/6/24 4:14:27 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/4/24 11:53:44 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amwell makes grant to new employee under inducement plan

      BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject to the employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the

      5/6/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to participate in upcoming investor conferences

      BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.    About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technolo

      4/24/25 7:30:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Leadership Updates

    Live Leadership Updates

    See more
    • Amwell announces new chief financial officer

      BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert "Bob" Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.   Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executiv

      10/15/24 4:30:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

      Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. "Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell's path to profitability. Ricky's strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team," said Ido Schoenberg, M.D., CEO and chairman, Amwell. Ms. Gol

      6/17/24 8:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

      ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven track record in driving strategic commercial initiatives, will serve on the Board's Governance, Nominating and Sustainability Committee, and the Quality, Compliance, and Portfolio Management Committee. "I am happy to welcome Kathy to the Board as Axogen is approaching an exciting inflection point in its journ

      12/26/23 4:15:00 PM ET
      $AMWL
      $AXGN
      Business Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMWL
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by American Well Corporation

      SCHEDULE 13G/A - American Well Corp (0001393584) (Subject)

      5/15/25 4:21:34 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by American Well Corporation

      10-Q - American Well Corp (0001393584) (Filer)

      5/1/25 4:13:22 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • American Well Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - American Well Corp (0001393584) (Filer)

      5/1/25 4:10:12 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Mcneice Paul Francis sold $747 worth of shares (113 units at $6.61), decreasing direct ownership by 0.78% to 14,366 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      6/4/25 5:01:52 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • President, International Gotlib Phyllis sold $31,628 worth of shares (4,782 units at $6.61), decreasing direct ownership by 3% to 141,849 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      6/4/25 5:01:14 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • President, International Gotlib Phyllis sold $2,155 worth of shares (299 units at $7.21), decreasing direct ownership by 0.20% to 146,631 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      5/5/25 4:31:36 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Amwell upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Amwell from Equal Weight to Overweight and set a new price target of $15.00

      1/13/25 7:29:38 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Amwell from Overweight to Equal-Weight and set a new price target of $2.50 from $5.00 previously

      8/3/23 6:19:10 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by TD Cowen with a new price target

      TD Cowen downgraded Amwell from Outperform to Market Perform and set a new price target of $2.50 from $5.00 previously

      3/23/23 7:15:52 AM ET
      $AMWL
      Business Services
      Consumer Discretionary